Zobrazeno 1 - 10
of 167
pro vyhledávání: '"O Ferrández"'
Autor:
J. Barceló-Vidal, D. Echeverría-Esnal, N. Carballo, M. De Antonio-Cuscó, X. Fernández-Sala, M. E. Navarrete-Rouco, E. Colominas-González, S. Luque, M. Fuster-Esteva, L. Domingo, M. Sala, X. Duran, S. Grau, O. Ferrández
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge about this type of infection
Externí odkaz:
https://doaj.org/article/d8c28ac897c1429aa94415c9d16ffb26
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 5, Pp 703-708 (2018)
Objective: Drug-related problems (DRP) produce high morbidity and mortality. It is therefore essential to identify patients at higher risk of these events. This study aimed to validate a DRP risk score in a large number of inpatients. Material and me
Externí odkaz:
https://doaj.org/article/e979e06e58514507aa816325e6478d97
Autor:
L Río-No, E Colominas-Gonzalez, N Carballo, X Fernández-Sala, C Bosch, M Ferran, F Gallardo, S Grau, O Ferrández
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74fc5b01d9b4253b890ff4ac28fa946
https://doi.org/10.1136/ejhpharm-2023-eahp.425
https://doi.org/10.1136/ejhpharm-2023-eahp.425
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A Rodriguez, S Gómez-Zorrilla, D Echeverría-Esnal, A Albalat, M De Antonio, O Ferrández, S Grau
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::613abb3a77a6f18d023eeea0a7d59983
https://doi.org/10.1136/ejhpharm-2022-eahp.257
https://doi.org/10.1136/ejhpharm-2022-eahp.257
Autor:
N. Carballo, J Monfort, O. Ferrández-Quirante, L Río-No, S. Grau-Cerrato, E. González-Colominas, C. Pérez, A Rodriguez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Patient adherence is a key determinant of treatment success in rheumatological immunomediated diseases. Available data about adherence to biological treatments and factors associated with non-adherence are limited in Spain.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd219b270557e32c566902f457e8e6c3
https://doi.org/10.1136/ejhpharm-2021-eahpconf.223
https://doi.org/10.1136/ejhpharm-2021-eahpconf.223
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Portabella, O. Urbina, S. Mojal, E. Salas, Santiago Grau, M Marín-Casino, J. Mateu-de-Antonio, M. Riu, O. Ferrández
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 42:201-208
SummaryWhat is known and objective Because of the impact of drug-related problems (DRPs) on morbidity and mortality, there is a need for computerized strategies to increase drug safety. The detection and identification of the causes of potential DRPs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3abef124362838323f5ef03eb778eb
https://doi.org/10.1111/jcpt.12495
https://doi.org/10.1111/jcpt.12495
Autor:
S. Grau, Carolina Pérez-García, M. E. Navarrete-Rouco, E. Garcia-Alzorriz Morral, O. Ferrández-Quirante, Jordi Monfort, N. Carballo, X. Duran, F. Cots
Publikováno v:
Annals of the Rheumatic Diseases. 80:991.2-992
Background:Rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic progressive immune-mediated rheumatic diseases (IMRD) that can cause a progressive disability and joint deformation and thus can impact in hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db922d25b37f7455c235bf85bb2edc4c
https://doi.org/10.1136/annrheumdis-2021-eular.3510
https://doi.org/10.1136/annrheumdis-2021-eular.3510
Autor:
C. Pérez, E. González-Colominas, O. Ferrández-Quirante, X. Duran, N. Carballo, L. Río, Jordi Monfort, S. Grau-Cerrato, A. Rodríguez-Alarcón
Publikováno v:
Annals of the Rheumatic Diseases. 80:1132.2-1132
Background:Patient adherence is a key determinant of treatment success in rheumatologic immune-mediated diseases. Available data about adherence to biological treatments and factors associated to non-adherence is limited in Spain. Moreover, no studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24436b9a8e71bbd16b17f730190d557c
https://doi.org/10.1136/annrheumdis-2021-eular.1304
https://doi.org/10.1136/annrheumdis-2021-eular.1304